Paul Duguid

OverviewAI-generated summary

Paul Duguid's research program focuses on understanding and addressing neuroinflammation, particularly its role in the cognitive deficits associated with Fetal Alcohol Spectrum Disorders (FASD). He has received significant federal funding from the National Institutes of Health (NIH) for this work, including grants from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) totaling over $830,000 to investigate dynamic neuroimmune interactions and the specific role of neuroinflammation in FASD-related cognitive impairments. Duguid also leads NIH-funded training programs, the Training in Systems Pharmacology and Toxicology (T-SPaT) and the Systems Pharmacology and Toxicology Training Program, aimed at preparing researchers in these critical fields. These programs have collectively received over $343,000 in funding from the National Institute of General Medical Sciences (NIGMS).

Beyond his primary research in neuroinflammation and FASD, Duguid's scholarly activities encompass a broader range of topics, reflecting a diverse academic background. His recent publications include work on understanding communities of practice, distinguishing translational science from translational research in clinical and translational science award pilot studies, and strategies for training under-represented researchers. He has also published on the history and heritage of science and technology, as well as the composition and enactment of telehealth practices. Duguid's scholarship is recognized by a high h-index of 30 and over 33,000 citations across his 110 publications, marking him as a highly cited researcher.

Metrics

• h-index: 30
• Publications: 110
• Citations: 33,431